125
125
Nov 1, 2014
11/14
by
CNBC
tv
eye 125
favorite 0
quote 0
we've seen it with danon and other companies that invested there. that is a big concern.ou know, so when i look at this i say, if everything's legit, and if you actually are getting your piece, the valuation is fine. >> are those issues going to come to a head, though, in the time spam of november? that's a very short-term period now. >> that's the battle played out right now. if we did not have those concerns the stock would be higher than it is now. >> let me tell you why i think we're talking about it. >> no, no. >> can't prove the negative. a weird thing. most of wall street, most analysts, investors, e they saw their ipo road show in late summer. a good look how they trade with wall street analysts. think back to facebook. a ipo. first publicly traded, stocked nealed. down 12% after the first call. twitter down 24%. this is a different animal. a massive company. i'm thinking this way. implied move in option the next week 6.5% in either direction. that's some serious market cap. okay? >> market trade. >> so simply -- if you have not been in this thing and don't have t
we've seen it with danon and other companies that invested there. that is a big concern.ou know, so when i look at this i say, if everything's legit, and if you actually are getting your piece, the valuation is fine. >> are those issues going to come to a head, though, in the time spam of november? that's a very short-term period now. >> that's the battle played out right now. if we did not have those concerns the stock would be higher than it is now. >> let me tell you why i...
111
111
Nov 27, 2014
11/14
by
BLOOMBERG
tv
eye 111
favorite 0
quote 0
a person familiar with the matter said danone has had internal discussions, and no decision has been made. alibaba plans to ramp up investment in india. chairman jack ma spoke about the plans at a conference in new delhi. >> we see such a great number of indian businesses using our business, which shows our great respect for the passion and capability of catching opportunities. >> jack ma will also be meeting with the ceo of india's largest e-commerce site. apple is raising the price of the iphone in russia by 25%. the reason -- the declining russian ruble. the ruble has lost a quarter of its value against the u.s. dollar since september, prompting tourists to buy iphones on the cheap in russia meantime, rival samsung has just cut the price of its galaxy s5 in russia. sony is developing a watch made out of electronic paper. the precise epaper technology is unclear, though people say the device will emphasize style over technology. now to our lead, uber shows no signs of slowing down. the ride-sharing company is set to raise funding at a $40 billion valuation. potentially with t. rowe
a person familiar with the matter said danone has had internal discussions, and no decision has been made. alibaba plans to ramp up investment in india. chairman jack ma spoke about the plans at a conference in new delhi. >> we see such a great number of indian businesses using our business, which shows our great respect for the passion and capability of catching opportunities. >> jack ma will also be meeting with the ceo of india's largest e-commerce site. apple is raising the...
81
81
Nov 27, 2014
11/14
by
BLOOMBERG
tv
eye 81
favorite 0
quote 0
danone has held discussions about a selloff according to people familiar with the matter.smithkline's ebola vaccine has been found safe and effective in the clinical trial. that is according to a report in the new england journal of medicine. the report is an initial step towards making the vaccine widely available as the ebola outbreak in western africa continues to spread. joining us for more this story -- sam, very good to see you this morning. what does this mean for those currently affected by ebola? >> this is the first step in developing a vaccine. what they have done here is take an small number of volunteers that are not necessaryfully the african region, in areas that are affected and tested the ability of the vaccine. the most crucial point being is it safe in the small number of . ople it was tested it has induced what we call an immune response. you don't know whether that was protective or not. only larger trial also tell. >> this is a small trial. 20 healthy adults in this trial. so what are the next steps then? is it more trials broadening this out? >> abso
danone has held discussions about a selloff according to people familiar with the matter.smithkline's ebola vaccine has been found safe and effective in the clinical trial. that is according to a report in the new england journal of medicine. the report is an initial step towards making the vaccine widely available as the ebola outbreak in western africa continues to spread. joining us for more this story -- sam, very good to see you this morning. what does this mean for those currently...
593
593
Nov 27, 2014
11/14
by
CNBC
tv
eye 593
favorite 0
quote 0
danone, pretty flat. it's considering selling a stake worth $11.9 million. the two companies last year, they ditched plans for a nine-year alliance opting for looser cooperation. and last but not least, weakening chinese demand has, again, hit the sales. but the maker of remy martin cognac is sticking to its full year outlook. stephane pedrazzi is in paris. don't you fancy a glass of cognac every now and again? is that up your alley? >> not really. but if you want to offer me a bottle of conyak for christmas, actually, there's the louis xiii cognac which sells for 2,500 europe bubbles. i'll think about it, stephane. sounds like a great present. >> well, some of the great presents in china so far. but you know the new anti-corruptions law in the country have risked significantly the maximum value in the business context in the country and thats the reason why it's suffering in china and that's the main reason behind the drop in first half profits. they are not selling such an expensive cognac. they weren't as exposed as remy. that being said, despite weak chi
danone, pretty flat. it's considering selling a stake worth $11.9 million. the two companies last year, they ditched plans for a nine-year alliance opting for looser cooperation. and last but not least, weakening chinese demand has, again, hit the sales. but the maker of remy martin cognac is sticking to its full year outlook. stephane pedrazzi is in paris. don't you fancy a glass of cognac every now and again? is that up your alley? >> not really. but if you want to offer me a bottle of...